Porokeratosis is a rare disorder of keratinization characterized by annular plaques with elevated hyperkeratotic borders and central atrophy. The disease may present in several clinical variants and is considered a premalignant dermatological condition due to its potential for malignant transformation into squamous cell carcinoma or basal cell carcinoma. The condition commonly affects sun-exposed areas and may be associated with genetic predisposition, immunosuppression, chronic sun exposure, and systemic illnesses.
We report the case of a 48-year-old female who presented with slowly progressive hyperpigmented annular plaques over the bilateral forearms and lower legs associated with mild itching and cosmetic concern for nearly three years. Clinical examination and dermoscopic evaluation suggested porokeratosis, which was later confirmed by histopathological examination demonstrating the characteristic cornoid lamella. The patient was managed with topical retinoids, sun protection measures, and cryotherapy for selected lesions, resulting in symptomatic improvement and stabilization of disease progression.
This case highlights the importance of early diagnosis, dermoscopic assessment, histopathological confirmation, regular surveillance for malignant transformation, and individualized therapeutic strategies in the management of porokeratosis.
Porokeratosis is a chronic keratinization disorder characterized by abnormal epidermal differentiation resulting in distinct annular lesions with raised keratotic borders. The hallmark histopathological feature is the presence of a cornoid lamella, which represents a thin column of parakeratotic cells extending through the stratum corneum.
The disease was first described by Mibelli in 1893 and includes several clinical variants such as:
Disseminated superficial actinic porokeratosis is among the most common variants and frequently affects middle-aged adults exposed to chronic ultraviolet radiation.
Important risk factors include:
Clinical manifestations vary according to the subtype and extent of disease involvement.
Common symptoms include:
Because porokeratosis is considered a premalignant condition, early diagnosis and regular dermatological monitoring are essential to prevent complications.
Patient History
A 48-year-old female presented to the dermatology outpatient department with:


The lesions initially appeared as small brownish papules and progressively enlarged over time forming annular plaques with raised margins.
The patient denied:
Past medical history revealed:
General Examination
Dermatological Examination
Cutaneous examination revealed:
The largest lesion measured approximately 4 cm in diameter.
Hair, nails, and mucosal examination were unremarkable.
No regional lymphadenopathy was noted.
Differential Diagnosis
The following conditions were considered:
The characteristic keratotic border and annular morphology strongly suggested porokeratosis.
Laboratory Findings
Routine laboratory investigations showed:
Dermoscopy
Dermoscopy demonstrated:

Skin Biopsy
Histopathological examination revealed:
The biopsy findings confirmed the diagnosis of porokeratosis.


Based on clinical findings, dermoscopic evaluation, and histopathological confirmation, a diagnosis of Disseminated Superficial Actinic Porokeratosis (DSAP) was established.
Conservative Management
The patient was advised:
Medical Therapy
Topical therapy included:
The patient was also advised oral antioxidant supplementation.
Procedural Management
Cryotherapy was performed for selected symptomatic and cosmetically concerning lesions.
Liquid nitrogen application was done in multiple sessions with appropriate intervals.
At 1 Month
At 3 Months
At 6 Months
The patient remained clinically stable during follow-up.

Pathophysiology
Porokeratosis results from abnormal epidermal keratinization caused by clonal proliferation of atypical keratinocytes.
Important pathological mechanisms include:
The characteristic cornoid lamella represents abnormal keratinocyte proliferation and defective cornification.
Epidemiology
Important epidemiological features include:
The incidence of porokeratosis is increasing due to greater ultraviolet exposure and improved recognition of dermatological disorders.
Clinical manifestations depend upon the subtype and extent of disease.
Common findings include:
Linear porokeratosis may carry a higher risk of malignant transformation.
Important diagnostic tools include:
Histopathology demonstrating cornoid lamella remains the gold standard diagnostic feature.
Conservative Therapy
Non-invasive management includes:
Pharmacological Therapy
Medical treatment options include:
Procedural Treatment
Procedures commonly used include:
Treatment selection depends upon lesion size, location, symptom severity, cosmetic concern, and risk of malignancy.
Porokeratosis is considered a premalignant condition.
Potential malignancies include:
Risk factors for malignant transformation include:
Regular follow-up and lesion surveillance are essential.
Potential complications include:
Delayed diagnosis may increase the risk of progression and skin malignancy.
The prognosis depends upon:
Most patients achieve symptomatic improvement with appropriate treatment and preventive strategies.
Porokeratosis is an uncommon but clinically important keratinization disorder with significant dermatological and oncological implications. Early recognition of annular keratotic plaques, careful dermoscopic evaluation, and histopathological confirmation are essential for accurate diagnosis.
This case emphasizes the importance of individualized management strategies involving sun protection, topical therapy, procedural interventions, and long-term dermatological surveillance to prevent complications and malignant transformation. Early intervention and regular follow-up remain critical in improving patient outcomes and quality of life.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Inner Thoughts of Leonard Bernstein, the "Maestro".
2.
Mobile prostate cancer screening clinic can ID the disease in disadvantaged men
3.
No Survival Benefit Seen With Adjuvant Atezolizumab in TNBC
4.
Parents, teachers at Missouri school want answers after string of cancer diagnoses
5.
A promising medication could slow brain tumors in children.
1.
Future-Ready Cancer Screening: What Every Clinician Should Know in 2025
2.
Cancer Evolution and Therapeutic Resistance: Mechanisms, Clinical Insights, and Emerging Strategies
3.
Targeting Cancer Stem Cells in Solid Tumors: Mechanisms, Clinical Implications, and Therapeutic Advances
4.
Partial Gland Ablation in Prostate Cancer: Oncologic Outcomes in Intermediate-Risk Cases
5.
Generative AI for Adaptive Oncology Trial Design
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
5.
Current Scenario of Cancer- The Incidence of Cancer in Men
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation